Iqbal, H.; Razzaq, A.; Uzair, B.; Ul Ain, N.; Sajjad, S.; Althobaiti, N.A.; Albalawi, A.E.; Menaa, B.; Haroon, M.; Khan, M.;
et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials 2021, 14, 3155.
https://doi.org/10.3390/ma14123155
AMA Style
Iqbal H, Razzaq A, Uzair B, Ul Ain N, Sajjad S, Althobaiti NA, Albalawi AE, Menaa B, Haroon M, Khan M,
et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials. 2021; 14(12):3155.
https://doi.org/10.3390/ma14123155
Chicago/Turabian Style
Iqbal, Haroon, Anam Razzaq, Bushra Uzair, Noor Ul Ain, Shamaila Sajjad, Norah Ayidh Althobaiti, Aishah Eid Albalawi, Bouzid Menaa, Muhammad Haroon, Muslim Khan,
and et al. 2021. "Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice" Materials 14, no. 12: 3155.
https://doi.org/10.3390/ma14123155
APA Style
Iqbal, H., Razzaq, A., Uzair, B., Ul Ain, N., Sajjad, S., Althobaiti, N. A., Albalawi, A. E., Menaa, B., Haroon, M., Khan, M., Khan, N. U., & Menaa, F.
(2021). Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials, 14(12), 3155.
https://doi.org/10.3390/ma14123155